Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.08
Delayed Data
As of Feb 23
 +0.15 / +3.04%
Today’s Change
4.01
Today|||52-Week Range
8.38
+9.25%
Year-to-Date

Today’s Trading

Previous close4.93
Today’s open4.94
Day’s range4.87 - 5.10
Volume834,764
Average volume (3 months)1,817,729
Market cap$605.4M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)+58.24%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc-0.14-0.55%
TGTXTG Therapeutics Inc+0.05+0.36%
BYSIBeyondspring Inc-0.91-3.51%
EGRXEagle Pharmaceutical...+1.84+2.83%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts